Application 021681
- Type
- NDA
- Sponsor
- MISSION PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TINDAMAX | TINIDAZOLE | TABLET; ORAL | 250MG | No | No |
| 002 | TINDAMAX | TINIDAZOLE | TABLET; ORAL | 500MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tinidazole | TINIDAZOLE | Edenbridge Pharmaceuticals LLC. | 6f3ce597-64c1-4204-a67a-8b6f6e7e8bca | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | TINIDAZOLE |
| Tinidazole | TINIDAZOLE | BioComp Pharma, Inc. | f55bcc41-2e8d-4ee5-9993-05c7d86f2d2c | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | TINIDAZOLE |
| Tindazole | TINIDAZOLE | Rising Pharma Holdings, Inc. | 32167dd7-5d37-457b-9b00-cd735de6b060 | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | TINIDAZOLE |
| Tinidazole | TINIDAZOLE | Chartwell RX, LLC | b39bc167-f1c4-4169-8b46-e6c2eafe6bbf | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | TINIDAZOLE |
| Tinidazole | TINIDAZOLE | Lupin Pharmaceuticals,Inc. | 95ab57b2-5d7e-4986-abcd-65edf1728383 | 2022-02-14 | Boxed warning, Warnings, Adverse reactions | TINIDAZOLE |
| Tindamax | TINIDAZOLE | Mission Pharmacal Company | a0d01539-8413-4703-94cc-d221918630a1 | 2021-12-27 | Boxed warning, Warnings, Adverse reactions | Tindamax TINIDAZOLE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 21777 | ORIG | 2005-02-02 |